• CTY share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • CTY stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • CTY market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

About CTY

City Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the development of RNAi therapeutics. The company was founded by John Maraganore, Sebastian Trousil, Ari Nowacek, Mark Keating, Kotaro Nakanishi, Yukihide Tomari, and Phillip Zamore on July 17, 2023 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

  • CTY market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Smart score

Latest CTY news

No recent TipRanks articles are available for CTY

No recent press releases are available for CTY

CTY Financials

1-year income & revenue

  • CTY total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • CTY net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • CTY earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

CTY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CTY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    CTY's competitors are included in the Health Technology sector and Biotechnology group

  • CTY market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Latest investing news